Targeting apoptosis in the hormone -and drug-resistant prostate canser cell line,DU-145, by gossypol/ zoledronic acid combination,
Overcoming drug resistance in hormone -and drug- refractory prostate canser cell line, PC-3 by docetaxel and gossypol combination,
Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-I and Ltbeta-R in hormone-and drug resistant prostate canser cell line, DU-145,
Docetaxel / zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate canser cells,
Profiling of angiogenic cytokines produced by hormone-and drug- refractory prostate canser cell Lines, PC-3 and DU-145 before and after treatment with gossypol
Renal Hücreli Karsinom, Troid ve Parotis Bezi Metastazı: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi
Rektal Skuamöz Hücreli Karsinom: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi
Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck canser